Clinical Trial Patient Recruitment Services Market is Segmented By Patient Recruitment Step (Pre-screening, Screening), By Trial Phase (Phase I, Phase....
Market Size in USD
CAGR8.2%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 8.2% |
Market Concentration | High |
Major Players | IQVIA, Syneos Health, Parexel, PPD, PRA Health Sciences |
The clinical trial patient recruitment services market is estimated to be valued at USD 9.4 Bn in 2024 and is expected to reach USD 19.1 Bn by 2031, growing at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031.
The market has been witnessing significant growth in recent years due to increase in the number of clinical trials conducted globally each year. Pharmaceutical and biotechnology companies have been outsourcing patient recruitment services to optimize costs and improve the recruitment process which has fueled demand. Furthermore, challenges in identifying eligible patients, difficulty in reaching out to a mass population, and lack of centralized databases have compelled clinical research organizations to rely on specialized patient recruitment service providers.